JP Morgan analyst Daniel Chen assumes Bilibili (NASDAQ:BILI) with a Overweight rating.
Where Regeneron Pharmaceuticals Stands With Analysts
Within the last quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…